Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novavax

FDA Vaccine Chief Claims COVID Shots Linked to 'At Least 10' Child Deaths but Offers No Data

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to COVID-19 vaccines without data to back it up.

International Business Times UK

Under the Radar: Why This 600M Fund Manager Keeps Outperforming Wall Street

While everyone else is running in circles over the next week breathlessly talking about what Buffett, Ackman, Pabrai and Woods are buying, I will be calmly going through the 13f filings of obscure money managers who know one has heard of, have little to no social media presence

Benzinga

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Novavax Shares Are Trading Higher Thursday: What's Going On?

Novavax, Inc. (NASDAQ:NVAX) shares are trading lower Thursday after the company announced it has extended its $225 million convertible notes deal. Additionally, B of A securities downgraded the stock yesterday from a Neutral rating to a Underperform rating and cut its price target from $9 to $7.

Benzinga

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales

On Wednesday, Novavax Inc. (NASDAQ:NVAX) reported second-quarter 2025 sales of $239.24 million, compared to $415 million a year ago, beating the consensus of $156.29 million.

Benzinga

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Shares of Novavax Inc (NASDAQ:NVAX) are trading lower Friday morning, appearing to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna Inc (NASDAQ:MRNA) reported disappointing second-quarter financial results and cut its full-year forecast.

Benzinga

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analysts Think These Stocks Could More Than Double in Value

Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.

MarketBeat

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter

The Independent UK

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

Health agencies working under Robert F

The Independent UK

FDA approves Novavax COVID-19 shot but with unusual restrictions

The Food and Drug Administration has approved Novavax's COVID-19 vaccine but with unusual restrictions

The Independent UK

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax

The Independent UK

How ‘revenge of the Covid contrarians’ unleashed by RFK Jr puts broader vaccine advances at risk

The health secretary has pledged to fight chronic illness, but experts say he risks increasing it with department cuts

The Guardian - US

Novavax says its COVID-19 shot is on track for full FDA approval after delay

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies'

Massive cuts to personnel and funding within the Department of Health and Human Services presents a headache for vaccine approval and development, analysts say.

Barchart

Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0

While vaccine-related investments have broadly suffered following Trump’s electoral victory, NVAX stock may represent a compelling compromise.

The Independent UK

Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread

LiveScience

Older adults should get 2 doses of the updated COVID shot, CDC says

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months apart.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

It's time to roll up sleeves for new COVID, flu shots

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines

Fortune

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

The Conversation

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

Fortune

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

The Independent UK

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

Salon

New COVID vaccines approved early

New shots from Pfizer and Moderna will be available within days. Here's how to get yours

The Independent UK

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

the Food and Drug Administration

194 stories

Sanofi

186 stories

the Department of Health and Human Services

126 stories

Moderna Inc

124 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.